Peter Salzmann - Jun 17, 2021 Form 4 Insider Report for Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Role
Director
Signature
/s/ Sean Moran, attorney-in-fact for Peter Salzmann
Stock symbol
CRBP
Transactions as of
Jun 17, 2021
Transactions value $
$0
Form type
4
Date filed
6/17/2021, 04:45 PM
Next filing
Aug 4, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRBP Stock Option (right to buy) Award $0 +58.2K $0.00 58.2K Jun 17, 2021 Common Stock 58.2K $2.07 Direct F1
transaction CRBP Stock Option (right to buy) Award $0 +58.2K $0.00 58.2K Jun 17, 2021 Common Stock 58.2K $2.07 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The annual option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant.
F2 Represents a special retention award comprised of options to purchase common stock. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant.